Overview
Top Medical Research Studies
Our findings revealed that when the mice were exposed to a compound known to induce inflammation, there was a noticeable rise in reactive oxygen species (ROS), signaling an increase in oxidative stress. This stress resulted in an uptick in certain harmful factors related to inflammation and cell death. However, when we introduced zinc as a supplement, it effectively reduced these damaging factors, alleviating inflammation and the resulting cell death in both the mouse stomach and cultured cells.
Overall, our study indicates that zinc supplementation can play a significant role in controlling inflammation and protecting against cellular damage caused by oxidative stress in chronic gastritis. By modulating the ROS/NF-κB signaling pathway, zinc demonstrates potential as a protective agent for gastric health.
Using a method called agar gel dilution, we found that 95% of the H. pylori strains tested were susceptible to ZnCl at a concentration of 40 μg/ml. This is a promising figure, especially when compared to 98% susceptibility for BSS and 79% for CLR. Interestingly, H. pylori isolates from patients with nonulcer dyspepsia and peptic ulcers showed similar levels of susceptibility to ZnCl.
It's important to note that while ZnCl demonstrated a significant antimicrobial effect against H. pylori, making it a potential candidate for treatment, the study also indicated that its effectiveness was comparable to CLR, but slightly less than BSS. This suggests that while ZnCl may be beneficial in treating H. pylori infections, it should not be viewed as a standalone solution, particularly in gastritis management.
Ultimately, our findings indicate that zinc chloride holds promise in tackling H. pylori, potentially contributing to improved treatment strategies for those suffering from gastritis and related disorders.
The study was structured with one group receiving the traditional 14-day standard treatment, which included esomeprazole, amoxicillin, and clarithromycin. The other group was treated with a 10-day regimen that added bismuth subcitrate and zinc carnosine to the same foundational therapies. After completing their courses, we retested the patients to assess the success of the eradication therapy.
Our findings revealed that the modified therapy group achieved a significantly higher eradication rate of 93.5% compared to just 69.6% in the standard treatment group. Besides dizziness, the side effects were similar between the two therapies, indicating that the addition of zinc carnosine did not introduce significant new risks.
This research suggests that zinc carnosine can be beneficial in enhancing the effectiveness of treatments for gastritis while maintaining a favorable safety profile. Therefore, those dealing with difficult-to-treat gastritis might find hope in this innovative approach.
Most Useful Reviews
Medical Researches
- All Researches
The study was structured with one group receiving the traditional 14-day standard treatment, which included esomeprazole, amoxicillin, and clarithromycin. The other group was treated with a 10-day regimen that added bismuth subcitrate and zinc carnosine to the same foundational therapies. After completing their courses, we retested the patients to assess the success of the eradication therapy.
Our findings revealed that the modified therapy group achieved a significantly higher eradication rate of 93.5% compared to just 69.6% in the standard treatment group. Besides dizziness, the side effects were similar between the two therapies, indicating that the addition of zinc carnosine did not introduce significant new risks.
This research suggests that zinc carnosine can be beneficial in enhancing the effectiveness of treatments for gastritis while maintaining a favorable safety profile. Therefore, those dealing with difficult-to-treat gastritis might find hope in this innovative approach.
To address his condition, the treatment regime included high protein supplements, proton pump inhibitors, and zinc-vitamin supplements. Over the course of five months, we observed a complete improvement in his symptoms. While this particular case emphasizes the role of zinc within a comprehensive treatment plan, it’s important to note that zinc was part of a multi-component strategy that makes it difficult to isolate its individual effects on gastritis directly.
Nonetheless, this case illustrates how early diagnosis and a well-structured treatment approach—integrating nutritional support—can lead to significant recovery in rare syndromes like CCS.
Our findings revealed that when the mice were exposed to a compound known to induce inflammation, there was a noticeable rise in reactive oxygen species (ROS), signaling an increase in oxidative stress. This stress resulted in an uptick in certain harmful factors related to inflammation and cell death. However, when we introduced zinc as a supplement, it effectively reduced these damaging factors, alleviating inflammation and the resulting cell death in both the mouse stomach and cultured cells.
Overall, our study indicates that zinc supplementation can play a significant role in controlling inflammation and protecting against cellular damage caused by oxidative stress in chronic gastritis. By modulating the ROS/NF-κB signaling pathway, zinc demonstrates potential as a protective agent for gastric health.
Our findings suggest that adding Polaprezinc to the triple therapy improved the eradication rates of the bacteria responsible for gastritis. Specifically, we observed a significant increase in successful treatment outcomes, indicating a potential advantage of Polaprezinc as a complementary approach.
However, it's important to note that while the combination therapy showed better results, both treatment groups reported similar instances of adverse events. This means that Polaprezinc appears to offer a beneficial effect on treatment outcomes without increasing side effects.
Despite these positive results, we recognize that the evidence is still limited. More extensive trials are needed to confirm these findings and establish Polaprezinc's role in gastritis management firmly. Overall, this treatment could be a promising addition but needs further exploration before becoming a standard approach.
Notably, we found that children with H. pylori had lower levels of serum ferritin and zinc compared to those without the infection. However, the copper levels remained unaffected. Interestingly, after treating the infected children, we observed significant improvements in their hemoglobin, ferritin, and zinc levels. This suggests that while zinc deficiency is often present in these patients, simply providing zinc treatment alone cannot solely isolate its specific impact on gastritis.
Furthermore, we noted that more severe gastritis correlated with lower hemoglobin and zinc levels, and higher transferrin receptor levels. Although zinc appears to play a crucial role in the overall health of these children, our findings indicate that its treatment effect should be viewed alongside other potential factors influencing gastritis recovery.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Gastritis is an inflammation of the stomach lining, which can lead to a range of symptoms including abdominal pain, nausea, vomiting, and indigestion. This condition can be acute, arising suddenly and lasting for a short period, or chronic, developing gradually and persisting over time. Various factors can contribute to gastritis, such as excessive alcohol consumption, prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs), bacterial infections (most notably Helicobacter pylori), and autoimmune disorders.
Treatment for gastritis often focuses on addressing the underlying cause and might include medications to reduce stomach acid, antibiotics for infections, and lifestyle modifications like avoiding irritating foods and beverages. While many people recover from gastritis with adequate care, it's important to consult a healthcare professional for a proper diagnosis and treatment plan. If left untreated, gastritis can lead to more serious complications, such as stomach ulcers or even an increased risk for gastric cancer.
Zinc is a versatile metal known for its various applications in industry and health. It is a bluish-white metallic element represented by the symbol Zn and atomic number 30 on the periodic table. Zinc is primarily used for galvanizing steel to prevent rusting, in the manufacturing of alloys, and as a component in batteries. Additionally, zinc plays a crucial role in biological processes, making it an essential trace element in the human diet. It is involved in immune function, protein synthesis, wound healing, and DNA synthesis, highlighting its importance in maintaining overall health and well-being.
Zinc is often recognized for its various health benefits, including its role in supporting the immune system and promoting wound healing. In the context of gastritis, which is an inflammation of the stomach lining, zinc may have a supportive role due to its potential anti-inflammatory properties and its involvement in cell regeneration. Some studies indicate that zinc supplements can help in healing gastric mucosal injuries and may alleviate symptoms associated with gastritis. However, the evidence is not definitive and varies based on the individual’s health status and the cause of their gastritis.
That said, it's essential to approach supplementation cautiously. While zinc can be beneficial, taking too much can lead to adverse effects, including nausea, diarrhea, and interference with the absorption of other essential minerals. If you suspect you have gastritis or are considering zinc supplements as part of your treatment plan, it’s always best to consult with a healthcare provider first. They can provide personalized advice and ensure that any supplements or changes in diet won't adversely affect your condition or interact with other medications you might be taking.
Based on user reviews, the time it typically takes to see results from taking zinc for gastritis can vary. One reviewer mentioned that they noticed remarkable improvements in digestion after about one month of use, highlighting how it aids stomach digestion particularly for those with gastritis ((Read Review)). Another user emphasized the importance of taking the supplement with food to avoid potential stomach irritation, especially for individuals suffering from gastritis, suggesting that experiences may vary depending on dosage and form ((Read Review)).
However, not all users have had a positive experience; one reviewer found that a different variant caused gastric mucosa irritation and worsened their gastritis, indicating that results can depend on individual responses and the specific formulation of the supplement being used ((Read Review)). Therefore, while some users report improvements within a month, others may experience negative effects, underscoring the importance of cautious use and dosage considerations.
The role of zinc in managing gastritis is increasingly supported by scientific research, showing its potential as a therapeutic agent. A systematic review evaluated Polaprezinc, a zinc-l-carnosine complex, and found that when used alongside standard triple therapy for gastritis caused by Helicobacter pylori, it significantly improved eradication rates compared to triple therapy alone [2]. Additionally, another study highlighted that zinc efficiently reduced inflammation and oxidative stress in chronic gastritis animal models, suggesting its protective benefits on gastric health [1].
Furthermore, investigations into zinc's influence on children with Helicobacter pylori gastritis revealed that, despite being associated with lower zinc levels in affected individuals, the treatment showed improved outcomes [3]. Another study established that zinc chloride exhibits a notable antimicrobial effect against H. pylori, reinforcing its potential role in gastritis management [7]. While these findings indicate that zinc and its compounds can enhance treatment for gastritis, further large-scale trials are needed for a clearer understanding of their effectiveness in clinical settings.
Users have reported a variety of improvements when taking zinc, particularly related to digestion, immunity, and physical characteristics. For example, one reviewer noted significant enhancements in their overall digestion after a month of use, as well as increased testosterone levels evidenced by changes in hair growth and darker hair on their hands ((Read Review)). Another user experienced stronger nails and improved immunity while emphasizing the importance of taking zinc with food to avoid stomach irritation, particularly for those with gastritis ((Read Review)).
However, these positive outcomes can vary widely among individuals. Some users have reported adverse effects, such as gastric irritation and exacerbated gastritis symptoms from certain zinc variants, indicating that individual tolerance and product formulation can significantly impact results ((Read Review)). This highlights the importance of carefully considering the specific type of zinc supplement being used and suggests that while many users find relief and improvements, others may experience challenges. Therefore, consulting with a healthcare professional before starting any new supplement regimen is advisable.
Users report a mixed experience when combining this zinc supplement with other products to manage gastritis. One user highlighted the benefits of taking zinc alongside vitamin D3, experiencing notable improvements in immunity and nail strength ((Read Review)). However, they also cautioned that taking the supplement in a larger dosage without food could inflame gastritis symptoms, suggesting that those with sensitive stomachs should prioritize taking it with substantial meals to mitigate any irritation effects.
Conversely, other users have shared less favorable experiences when combining zinc with other supplements. One reviewer noted that a particular variant of zinc caused gastric mucosa irritation and worsened their gastritis symptoms, leading to a preference for capsules over tablets ((Read Review)). This indicates that while some individuals find success and relief by stacking zinc with additional nutrients, others experience adverse effects, emphasizing the need for caution and personal experimentation when integrating multiple supplements for gastritis.
Based on user reviews, it appears that the right dosage of zinc for treating gastritis can vary significantly among individuals. Some users have found that splitting large pills can be beneficial, especially since high dosages may lead to stomach irritation. One user mentioned that they experienced improved digestion and normalization of stomach functions after taking zinc, but they also advised caution due to the high dosage, suggesting that one should split the tablet for better tolerance (Read Review). Another user echoed this sentiment, noting that taking zinc with a substantial meal is essential to reduce the risk of exacerbating gastritis symptoms, particularly when consuming larger doses (Read Review).
Conversely, some users reported adverse effects associated with zinc supplementation. For instance, one user noted that a particular zinc variant caused gastric mucosa irritation, which emphasizes the importance of formulation choice as well as dosage (Read Review). Users are generally recommending caution and customization of dosage based on individual digestive responses, emphasizing a careful approach to using zinc for managing gastritis.
Our findings suggest that adding Polaprezinc to the triple therapy improved the eradication rates of the bacteria responsible for gastritis. Specifically, we observed a significant increase in successful treatment outcomes, indicating a potential advantage of Polaprezinc as a complementary approach.
However, it's important to note that while the combination therapy showed better results, both treatment groups reported similar instances of adverse events. This means that Polaprezinc appears to offer a beneficial effect on treatment outcomes without increasing side effects.
Despite these positive results, we recognize that the evidence is still limited. More extensive trials are needed to confirm these findings and establish Polaprezinc's role in gastritis management firmly. Overall, this treatment could be a promising addition but needs further exploration before becoming a standard approach.
Our findings revealed that when the mice were exposed to a compound known to induce inflammation, there was a noticeable rise in reactive oxygen species (ROS), signaling an increase in oxidative stress. This stress resulted in an uptick in certain harmful factors related to inflammation and cell death. However, when we introduced zinc as a supplement, it effectively reduced these damaging factors, alleviating inflammation and the resulting cell death in both the mouse stomach and cultured cells.
Overall, our study indicates that zinc supplementation can play a significant role in controlling inflammation and protecting against cellular damage caused by oxidative stress in chronic gastritis. By modulating the ROS/NF-κB signaling pathway, zinc demonstrates potential as a protective agent for gastric health.
Notably, we found that children with H. pylori had lower levels of serum ferritin and zinc compared to those without the infection. However, the copper levels remained unaffected. Interestingly, after treating the infected children, we observed significant improvements in their hemoglobin, ferritin, and zinc levels. This suggests that while zinc deficiency is often present in these patients, simply providing zinc treatment alone cannot solely isolate its specific impact on gastritis.
Furthermore, we noted that more severe gastritis correlated with lower hemoglobin and zinc levels, and higher transferrin receptor levels. Although zinc appears to play a crucial role in the overall health of these children, our findings indicate that its treatment effect should be viewed alongside other potential factors influencing gastritis recovery.
Using a method called agar gel dilution, we found that 95% of the H. pylori strains tested were susceptible to ZnCl at a concentration of 40 μg/ml. This is a promising figure, especially when compared to 98% susceptibility for BSS and 79% for CLR. Interestingly, H. pylori isolates from patients with nonulcer dyspepsia and peptic ulcers showed similar levels of susceptibility to ZnCl.
It's important to note that while ZnCl demonstrated a significant antimicrobial effect against H. pylori, making it a potential candidate for treatment, the study also indicated that its effectiveness was comparable to CLR, but slightly less than BSS. This suggests that while ZnCl may be beneficial in treating H. pylori infections, it should not be viewed as a standalone solution, particularly in gastritis management.
Ultimately, our findings indicate that zinc chloride holds promise in tackling H. pylori, potentially contributing to improved treatment strategies for those suffering from gastritis and related disorders.
References
- Sun X, Xu S, Liu T, Wu J, Yang J, et al. Zinc supplementation alleviates oxidative stress to inhibit chronic gastritis the ROS/NF-κB pathway in a mouse model. Food Funct. 2024;15:7136. doi:10.1039/d4fo01142b
- Mahmoud A, Abuelazm M, Ahmed AAS, Abdalshafy H, Abdelazeem B, et al. Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2022;14. doi:10.3390/nu14194126
- Elsaadany E, Amin S, Abdel-Hafez M, El Amrousy D, Kasem S, et al. Study of Serum Ferritin, Zinc, and Copper Levels in Children With Helicobacter pylori Gastritis and the Effect of the Treatment. J Pediatr Gastroenterol Nutr. 2022;75:e88. doi:10.1097/MPG.0000000000003585
- Lenti MV, Facciotti F, Miceli E, Vanoli A, Fornasa G, et al. Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis. Clin Transl Gastroenterol. 2022;13:e00510. doi:10.14309/ctg.0000000000000510
- Ibrahim N, El Said H, Choukair A. Zinc carnosine-based modified bismuth quadruple therapy standard triple therapy for eradication: A randomized controlled study. World J Clin Cases. 2022;10:227. doi:10.12998/wjcc.v10.i1.227
- Tan B, Luo HQ, Xu H, Lv NH, Shi RH, et al. Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. PLoS One. 2017;12:e0175625. doi:10.1371/journal.pone.0175625
- Yakoob J, Abbas Z, Usman MW, Awan S, Naz S, et al. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori. Microb Drug Resist. 2014;20:305. doi:10.1089/mdr.2013.0086
- Lipin SP, Paul B, Nazimudeen E, Jacob BS. Case of Cronkhite Canada syndrome shows improvement with enteral supplements. J Assoc Physicians India. 2012;60:61.
